Literature DB >> 32858236

Guidelines for Statistical Reporting in Medical Journals.

Fang-Shu Ou1, Jennifer G Le-Rademacher2, Karla V Ballman3, Alex A Adjei4, Sumithra J Mandrekar2.   

Abstract

Statistical methods are essential in medical research. They are used for data analysis and drawing appropriate conclusions. Clarity and accuracy of statistical reporting in medical journals can enhance readers' understanding of the research conducted and the results obtained. In this manuscript, we provide guidelines for statistical reporting in medical journals for authors to consider, with a focus on the Journal of Thoracic Oncology.
Copyright © 2020 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Keywords:  Medical journals; Presenting; Reporting; Statistical results; p value

Year:  2020        PMID： 32858236      PMCID： PMC7642026          DOI： 10.1016/j.jtho.2020.08.019

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


  11 in total

Review 1.  Biomarker: Predictive or Prognostic?

Authors:  Karla V Ballman
Journal:  J Clin Oncol       Date:  2015-09-21       Impact factor: 44.544

2.  The (in)famous GWAS P-value threshold revisited and updated for low-frequency variants.

Authors:  João Fadista; Alisa K Manning; Jose C Florez; Leif Groop
Journal:  Eur J Hum Genet       Date:  2016-01-06       Impact factor: 4.246

3.  Forest plots and the interpretation of subgroups.

Authors:  Jack Cuzick
Journal:  Lancet       Date:  2005 Apr 9-15       Impact factor: 79.321

4.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Lancet       Date:  2007-10-20       Impact factor: 79.321

5.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  Ann Intern Med       Date:  2009-07-20       Impact factor: 25.391

6.  A note on quantifying follow-up in studies of failure time.

Authors:  M Schemper; T L Smith
Journal:  Control Clin Trials       Date:  1996-08

7.  CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.

Authors:  Kenneth F Schulz; Douglas G Altman; David Moher
Journal:  Trials       Date:  2010-03-24       Impact factor: 2.279

Review 8.  Clinical trial designs incorporating predictive biomarkers.

Authors:  Lindsay A Renfro; Himel Mallick; Ming-Wen An; Daniel J Sargent; Sumithra J Mandrekar
Journal:  Cancer Treat Rev       Date:  2016-01-05       Impact factor: 12.111

9.  STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration.

Authors:  Jérémie F Cohen; Daniël A Korevaar; Douglas G Altman; David E Bruns; Constantine A Gatsonis; Lotty Hooft; Les Irwig; Deborah Levine; Johannes B Reitsma; Henrica C W de Vet; Patrick M M Bossuyt
Journal:  BMJ Open       Date:  2016-11-14       Impact factor: 2.692

10.  Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations.

Authors:  Sander Greenland; Stephen J Senn; Kenneth J Rothman; John B Carlin; Charles Poole; Steven N Goodman; Douglas G Altman
Journal:  Eur J Epidemiol       Date:  2016-05-21       Impact factor: 8.082
View more
  2 in total

1.  Effect of Vitamin D Supplementation on the Cerebral Placental Ratio in Pregnancy Complicated with Early Fetal Growth Restriction.

Authors:  Karolina Jakubiec-Wisniewska; Hubert Huras; Magdalena Kolak
Journal:  J Clin Med       Date:  2022-05-07       Impact factor: 4.964

2.  Statistical Considerations for Subgroup Analyses.

Authors:  Xiaofei Wang; Steven Piantadosi; Jennifer Le-Rademacher; Sumithra J Mandrekar
Journal:  J Thorac Oncol       Date:  2020-12-26       Impact factor: 15.609
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.